West Pharmaceutical Services, Inc. (NYSE: WST) is set to release its second-quarter 2023 financial results next week on Thursday, July 27.
The global leader in innovative solutions for injectable drug administration will then host a conference call at 9:00 a.m. Eastern Time to discuss their results and business outlook. Stay tuned for further developments as West Pharmaceutical Services prepares to share their latest financial numbers with the public.
Register now to join the conference call and have the opportunity to ask questions to Management! Upon registering, you’ll receive a unique PIN number which will grant access to the call. Don’t miss out on this chance to gain valuable insights directly from the decision makers. Get ready to be part of the conversation and sign up today!
On our conference call, our management team will be referring to an accompanying presentation. Visit our website on the day of the call to view it in the “Presentations” tab in the “Investors” section. For those unable to join, a replay of the call will be available on our website for the next 30 days.
About West
West Pharmaceutical Services, Inc. is a committed partner to drug developers, striving to provide top-tier, life-saving and life-enhancing injectable solutions and services. With a global team of 10,000 across 50 sites, West facilitates the safe and secure delivery of over 47 billion components and devices year after year. As a leader in this field, West upholds the highest standards for its customers and works hard to improve the quality of life for all.
West celebrates its 100-year anniversary in 2023, having served as a global leader in healthcare innovation and patient experience. Based out of Exton, Pennsylvania, West’s fiscal year 2022 saw net sales of $2.89 billion, reflecting the trust that investors have placed in the company, which is fortunate enough to be part of the Standard & Poor’s 500 index and traded on the New York Stock Exchange (NYSE: WST).